Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R

Matteo G. Della Porta, Emilio Paolo Alessandrino, Andrea Bacigalupo, Maria Teresa Van Lint, Luca Malcovati, Cristiana Pascutto, Michele Falda, Massimo Bernardi, Francesco Onida, Stefano Guidi, Anna Paola Iori, Raffaella Cerretti, Paola Marenco, Pietro Pioltelli, Emanuele Angelucci, Rosi Oneto, Francesco Ripamonti, Paolo Bernasconi, Alberto Bosi, Mario CazzolaAlessandro Rambaldi

Research output: Contribution to journalArticlepeer-review

Abstract

Approximately one-third of patients with myelodysplastic syndrome (MDS) receiving allogeneic hematopoietic stem cell transplantation (HSCT) are cured by this treatment. Treatment failure maybe due to transplant complications or relapse. To identify predictive factors for transplantation outcome, we studied 519 patients with MDS or oligoblastic acute myeloid leukemia (AML,

Original languageEnglish
Pages (from-to)2333-2342
Number of pages10
JournalBlood
Volume123
Issue number15
DOIs
Publication statusPublished - Apr 10 2014

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Fingerprint Dive into the research topics of 'Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R'. Together they form a unique fingerprint.

Cite this